Sep 262017
 

By Talent4Boards Team

Talent4Boards – Great Talent builds Great Boards

– USA, NC – Argos Therapeutics Inc. (NASDAQ:ARGS), an immuno-oncology company focused on the development and commercialization of individualized immunotherapies based on the Arcelis® precision immunotherapy technology platform, today announced the appointment of Richard Morrison, PhD, to the Company’s board of directors.… => Read more

Argos Therapeutics appoints Richard Morrison to its Board of Directors

From:: Argos Therapeutics appoints Richard Morrison to its Board of Directors

Sorry, the comment form is closed at this time.

%d bloggers like this: